Twist Bioscience Corporation
Twist Bioscience Corporation (TWST) Revenue
Annual & quarterly revenue history · segment & region breakdown
TWST · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsTwist Bioscience Corporation trailing twelve-month (TTM) revenue is $0.41B, an increase of 20.32% year-over-year from $0.38B in FY2025.
Revenue trend
2025 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-09-30 | $0.38B | +$0.06B | +20.32% |
| 2024-09-30 | $0.31B | +$0.07B | +27.69% |
| 2023-09-30 | $0.25B | +$0.04B | +20.41% |
| 2022-09-30 | $0.20B | +$0.07B | +53.83% |
| 2021-09-30 | $0.13B | +$0.04B | +46.87% |
| 2020-09-30 | $0.09B | +$0.04B | +65.67% |
| 2019-09-30 | $0.05B | +$0.03B | +113.89% |
| 2018-09-30 | $0.03B | +$0.01B | +136.16% |
| 2017-09-30 | $0.01B | +$0.01B | +374.53% |
| 2016-09-30 | $0.00B | — | — |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare TWST revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Twist Bioscience Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Twist Bioscience Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Twist Bioscience Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
TWST revenue · 4 questionsTWST's trailing twelve-month (TTM) revenue is $0.41B. That is an increase of 20.32% year-over-year from $0.38B in FY2025.
▸ Source: FMP · Twist Bioscience Corporation SEC filings · GAAP · Twist Bioscience Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026